Sanofi (SNY) Tops Q2 EPS by 83c; raises FY23 guidance

Sanofi (NASDAQ: SNY) reported Q2 EPS of EUR1.74, EUR0.83 better than the analyst estimate of EUR0.91. Revenue for the quarter came in at EUR9.96 billion versus the consensus estimate of EUR11.45 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat